1
|
Caricilli AM, Picardi PK, de Abreu LL, Ueno M, Prada PO, Ropelle ER, Hirabara SM, Castoldi Â, Vieira P, Camara NOS, Curi R, Carvalheira JB, Saad MJA. Retraction: Gut Microbiota Is a Key Modulator of Insulin Resistance in TLR 2 Knockout Mice. PLoS Biol 2016; 14:e1002479. [PMID: 27213533 PMCID: PMC4876994 DOI: 10.1371/journal.pbio.1002479] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022] Open
|
2
|
Lima MHM, Caricilli AM, de Abreu LL, Araújo EP, Pelegrinelli FF, Thirone ACP, Tsukumo DM, Pessoa AFM, dos Santos MF, de Moraes MA, Carvalheira JBC, Velloso LA, Saad MJA. Topical insulin accelerates wound healing in diabetes by enhancing the AKT and ERK pathways: a double-blind placebo-controlled clinical trial. PLoS One 2012; 7:e36974. [PMID: 22662132 PMCID: PMC3360697 DOI: 10.1371/journal.pone.0036974] [Citation(s) in RCA: 119] [Impact Index Per Article: 9.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/27/2011] [Accepted: 04/15/2012] [Indexed: 02/07/2023] Open
Abstract
BACKGROUND Wound healing is impaired in diabetes mellitus, but the mechanisms involved in this process are virtually unknown. Proteins belonging to the insulin signaling pathway respond to insulin in the skin of rats. OBJECTIVE The purpose of this study was to investigate the regulation of the insulin signaling pathway in wound healing and skin repair of normal and diabetic rats, and, in parallel, the effect of a topical insulin cream on wound healing and on the activation of this pathway. RESEARCH DESIGN AND METHODS We investigated insulin signaling by immunoblotting during wound healing of control and diabetic animals with or without topical insulin. Diabetic patients with ulcers were randomized to receive topical insulin or placebo in a prospective, double-blind and placebo-controlled, randomized clinical trial (NCT 01295177) of wound healing. RESULTS AND CONCLUSIONS Expression of IR, IRS-1, IRS-2, SHC, ERK, and AKT are increased in the tissue of healing wounds compared to intact skin, suggesting that the insulin signaling pathway may have an important role in this process. These pathways were attenuated in the wounded skin of diabetic rats, in parallel with an increase in the time of complete wound healing. Upon topical application of insulin cream, the wound healing time of diabetic animals was normalized, followed by a reversal of defective insulin signal transduction. In addition, the treatment also increased expression of other proteins, such as eNOS (also in bone marrow), VEGF, and SDF-1α in wounded skin. In diabetic patients, topical insulin cream markedly improved wound healing, representing an attractive and cost-free method for treating this devastating complication of diabetes. TRIAL REGISTRATION ClinicalTrials.gov NCT01295177.
Collapse
Affiliation(s)
- Maria H. M. Lima
- Department of Nursing, FCM, University of Campinas, Campinas, São Paulo, Brazil
| | - Andréa M. Caricilli
- Department of Internal Medicine, FCM, University of Campinas, Campinas, São Paulo, Brazil
| | - Lélia L. de Abreu
- Department of Nursing, FCM, University of Campinas, Campinas, São Paulo, Brazil
| | - Eliana P. Araújo
- Department of Nursing, FCM, University of Campinas, Campinas, São Paulo, Brazil
| | | | - Ana C. P. Thirone
- Department of Internal Medicine, FCM, University of Campinas, Campinas, São Paulo, Brazil
| | - Daniela M. Tsukumo
- Department of Internal Medicine, FCM, University of Campinas, Campinas, São Paulo, Brazil
| | - Ana Flávia M. Pessoa
- Department of Cell and Developmental Biology, University of São Paulo, São Paulo, Brazil
| | | | - Maria A. de Moraes
- Department of Internal Medicine, FCM, University of Campinas, Campinas, São Paulo, Brazil
| | - José B. C. Carvalheira
- Department of Internal Medicine, FCM, University of Campinas, Campinas, São Paulo, Brazil
| | - Lício A. Velloso
- Department of Internal Medicine, FCM, University of Campinas, Campinas, São Paulo, Brazil
| | - Mario J. A. Saad
- Department of Internal Medicine, FCM, University of Campinas, Campinas, São Paulo, Brazil
| |
Collapse
|
3
|
Caricilli AM, Picardi PK, de Abreu LL, Ueno M, Prada PO, Ropelle ER, Hirabara SM, Castoldi Â, Vieira P, Camara NOS, Curi R, Carvalheira JB, Saad MJA. Gut microbiota is a key modulator of insulin resistance in TLR 2 knockout mice. PLoS Biol 2011; 9:e1001212. [PMID: 22162948 PMCID: PMC3232200 DOI: 10.1371/journal.pbio.1001212] [Citation(s) in RCA: 213] [Impact Index Per Article: 16.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/11/2011] [Accepted: 10/27/2011] [Indexed: 02/07/2023] Open
Abstract
A genetic and pharmacological approach reveals novel insights into how changes in gut microbiota can subvert genetically predetermined phenotypes from lean to obese. Environmental factors and host genetics interact to control the gut microbiota, which may have a role in the development of obesity and insulin resistance. TLR2-deficient mice, under germ-free conditions, are protected from diet-induced insulin resistance. It is possible that the presence of gut microbiota could reverse the phenotype of an animal, inducing insulin resistance in an animal genetically determined to have increased insulin sensitivity, such as the TLR2 KO mice. In the present study, we investigated the influence of gut microbiota on metabolic parameters, glucose tolerance, insulin sensitivity, and signaling of TLR2-deficient mice. We investigated the gut microbiota (by metagenomics), the metabolic characteristics, and insulin signaling in TLR2 knockout (KO) mice in a non-germ free facility. Results showed that the loss of TLR2 in conventionalized mice results in a phenotype reminiscent of metabolic syndrome, characterized by differences in the gut microbiota, with a 3-fold increase in Firmicutes and a slight increase in Bacteroidetes compared with controls. These changes in gut microbiota were accompanied by an increase in LPS absorption, subclinical inflammation, insulin resistance, glucose intolerance, and later, obesity. In addition, this sequence of events was reproduced in WT mice by microbiota transplantation and was also reversed by antibiotics. At the molecular level the mechanism was unique, with activation of TLR4 associated with ER stress and JNK activation, but no activation of the IKKβ-IκB-NFκB pathway. Our data also showed that in TLR2 KO mice there was a reduction in regulatory T cell in visceral fat, suggesting that this modulation may also contribute to the insulin resistance of these animals. Our results emphasize the role of microbiota in the complex network of molecular and cellular interactions that link genotype to phenotype and have potential implications for common human disorders involving obesity, diabetes, and even other immunological disorders. An intricate interaction between genetic and environmental factors influences the development of obesity and diabetes. Previous studies have shown that mice lacking an important receptor of the innate immune system, Toll-like Receptor 2 (TLR2), are protected from insulin resistance. Given that the innate immune system has emerged as a key regulator of the gut microbiota, we undertook to investigate in this study whether the gut microbiota have a role in modulating the response to insulin. By rearing these TLR2 mutant mice in conventional facilities (as opposed to “germ-free” conditions) we figured that they would develop an altered gut microbiota. In contrast to previous studies, our results show that these TLR2 mutant mice now develop a diseased phenotype reminiscent of metabolic syndrome, including weight gain, and end up with gut microbiota similar to that found in obese mice and humans. These mice could be rescued by treatment with broad-spectrum antibiotics, which decimated the microbiota. Conversely, transplantation of the gut microbiota from these mice to wild-type mice induced weight gain and the metabolic syndrome phenotype. Our results indicate that the gut microbiota per se can subvert a genetically predetermined condition previously described as being protective towards obesity and insulin resistance into a phenotype associated with weight gain and its complications, such as glucose intolerance and diabetes.
Collapse
Affiliation(s)
- Andréa M. Caricilli
- Department of Internal Medicine, State University of Campinas, Campinas, Brazil
| | - Paty K. Picardi
- Department of Internal Medicine, State University of Campinas, Campinas, Brazil
| | - Lélia L. de Abreu
- Department of Nursing, State University of Campinas, Campinas, Brazil
| | - Mirian Ueno
- Department of Internal Medicine, State University of Campinas, Campinas, Brazil
| | - Patrícia O. Prada
- Department of Internal Medicine, State University of Campinas, Campinas, Brazil
| | - Eduardo R. Ropelle
- Department of Internal Medicine, State University of Campinas, Campinas, Brazil
| | - Sandro Massao Hirabara
- Department of Physiology and Biophysics, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil
| | - Ângela Castoldi
- Department of Immunology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil
| | - Pedro Vieira
- Department of Immunology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil
| | - Niels O. S. Camara
- Department of Immunology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil
| | - Rui Curi
- Department of Physiology and Biophysics, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil
| | - José B. Carvalheira
- Department of Internal Medicine, State University of Campinas, Campinas, Brazil
| | - Mário J. A. Saad
- Department of Internal Medicine, State University of Campinas, Campinas, Brazil
- * E-mail:
| |
Collapse
|
4
|
Caricilli AM, Nascimento PH, Pauli JR, Tsukumo DML, Velloso LA, Carvalheira JB, Saad MJA. Inhibition of toll-like receptor 2 expression improves insulin sensitivity and signaling in muscle and white adipose tissue of mice fed a high-fat diet. J Endocrinol 2008; 199:399-406. [PMID: 18787058 DOI: 10.1677/joe-08-0354] [Citation(s) in RCA: 101] [Impact Index Per Article: 6.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]
Abstract
The aims of the present study were to investigate the expression of toll-like receptor 2 (TLR2) in muscle and white adipose tissue (WAT) of diet-induced obesity (DIO) mice, and also the effects of its inhibition, with the use of TLR2 antisense oligonucleotide (ASON), on insulin sensitivity and signaling. The expression of TLR2 was increased in muscle and WAT of DIO mice, compared with those that received standard chow. Inhibition of TLR2 in DIO mice, by TLR2 ASON, improved insulin sensitivity and signaling in muscle and WAT. In addition, data show that the inhibition of TLR2 expression prevents the activation of IKBKB, MAPK8, and serine phosphorylation of IRS1 in DIO mice, suggesting that TLR2 is a key modulator of the crosstalk between inflammatory and metabolic pathways. We, therefore, suggest that a selective interference with TLR2 presents an attractive opportunity for the treatment of insulin resistance in obesity and type 2 diabetes.
Collapse
Affiliation(s)
- Andréa M Caricilli
- Department of Internal Medicine, State University of Campinas, 13081-970 Campinas, SP, Brazil
| | | | | | | | | | | | | |
Collapse
|